Salbroxol (ambroxol, salbutamol) tablets №20

$5.00

Manufacturer: Ukraine

Purpose: Ambroxol thins mucus, salbutamol relaxes airways; treat respiratory conditions.

SKU: MED61129 Categories: , ,

Description

Salbroxol (Ambroxol, Salbutamol) Tablets №20

Ingredients

  • Each tablet contains Ambroxol 30mg and Salbutamol 2mg.

Dosage

  • Adults: Take 1 tablet three times a day.
  • Children: Consult a healthcare professional for appropriate dosage.

Indications

Salbroxol tablets are indicated for the treatment of respiratory conditions such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD).

Contraindications

Do not use Salbroxol tablets if you are allergic to Ambroxol, Salbutamol, or any other ingredients in the formulation. Consult your doctor before use if you have a history of heart conditions or high blood pressure.

Directions

Swallow the tablets whole with a glass of water. Do not crush or chew the tablets. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence

Ambroxol is known for its mucolytic properties, helping to break down mucus in the airways, making it easier to cough up. Salbutamol is a bronchodilator that relaxes the muscles in the airways, facilitating breathing. The combination of these ingredients in Salbroxol tablets provides dual action in treating respiratory conditions.

Additional Information

  • Complete the full course of treatment with Salbroxol tablets as prescribed, even if symptoms improve.
  • If severe side effects or allergic reactions occur, seek medical attention promptly.

Pharmacological studies indicate that Ambroxol enhances surfactant production in the lungs, improving lung function and reducing respiratory infection risk. Salbutamol stimulates beta-2 adrenergic receptors in the airways, leading to bronchodilation and improved airflow.

Clinical trials have shown the efficacy of Ambroxol and Salbutamol in improving respiratory symptoms. Research published in the International Journal of Chronic Obstructive Pulmonary Disease demonstrated significant lung function and symptom control improvements in COPD patients treated with the Ambroxol-Salbutamol combination.